![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Indosol Drugs Limited Mumbai In, based in India, is a pharmaceutical company.
One of their significant offerings is Sulfamethoxazole, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R1-CEP 1998-049 - Rev 00
This Chemical Type CEP, issued on February 01, 2004, remains in force until May 26, 2008, ensuring its reliability within the pharmaceutical industry.
Substance Number 108 associated with this CEP further emphasizes